1/102
A comprehensive vocabulary review of 100 high-yield nursing concepts covering shock states, hemodynamics, AKI, CKD, renal replacement therapies, hepatology, transplant care, acid-base balance, pharmacology, and emergency protocols.
Initial Stage of Shock
The subclinical early phase of shock characterized by a baseline heart rate of ≤100bpm, normal blood pressure, normal respiratory rate, urine output of ≥30mL/hr, and cool, pink, dry skin.
Compensatory Stage of Shock
The phase of shock where neuroendocrine mechanisms maintain perfusion, presenting with a heart rate of >100bpm, normal to slight increase in blood pressure, respirations of 20–30/min, urine output of 20–30mL/hr, and cold, pale, dry or moist skin.
Progressive Stage of Shock
The decompensating phase of shock marked by compensatory failure, presenting with a heart rate of ≥120bpm, blood pressure drop to 70–90mmHg, respirations of 30–40/min, oliguria of 5–20mL/hr, and cold, pale, moist skin.
Refractory Stage of Shock
The irreversible, terminal phase of shock ("TOO LATE!!") characterized by profound failure across systems: heart rate of ≥140bpm, blood pressure of <50–60mmHg, respirations of ≥40/min, negligible urine output, and cold, mottled, cyanotic, dry skin.
Mean Arterial Pressure (MAP) in Shock Recovery
The primary hemodynamic parameter indicating clinical improvement from hypoperfusion, defined as achieving and maintaining a MAP≥65mmHg with a stable pulse pressure and normalization of blood pressure toward baseline.
Early Neurological Cue of Hypoperfusion
Subtle neurological shifts—specifically new anxiety, restlessness, apprehension, agitation, lethargy, or acute mild confusion—reflecting early cerebral hypoperfusion and representing the very first clinical sign of patient deterioration.
Hypovolemic Shock ("Empty Tank")
A fluid deficit shock state caused by hemorrhage, severe burns, third spacing, or gastrointestinal loss; hallmark assessment cues include flat neck veins, low central venous pressure (CVP), tachycardia, cool skin, and oliguria.
Modified Trendelenburg Position
The priority therapeutic positioning for hypovolemic shock where the client's legs are elevated 30∘–45∘ while avoiding a steep tilt of the trunk to optimize venous return to the heart.
Cardiogenic Shock ("Pump Failure")
A severe contractility loss shock state triggered by anterior left ventricular myocardial infarction, valve rupture, or end-stage heart failure; cues include high pulmonary artery wedge pressure (PAWP), elevated CVP, jugular venous distention (JVD), S3 heart sound, bilateral crackles, and pulmonary edema.
Dobutamine in Cardiogenic Shock
A first-line positive inotropic support medication administered in cardiogenic shock to increase myocardial contractility and stroke volume without drastically accelerating heart rate.
Septic Shock ("Infection Leak")
A distributive shock state caused by a dysregulated immune response to infection triggering cytokines, histamines, and prostaglandins, leading to widespread vasodilation and capillary leak; early cues include warm, bounding pulses, while late stages exhibit cold hypoperfusion and elevated serum lactate.
Hour-1 Sepsis Resuscitation Bundle
A golden-hour resuscitation protocol requiring: 1) Measure lactate (remeasure if initial >2.0mmol/L), 2) Obtain blood cultures ×2 prior to antibiotics, 3) Administer broad-spectrum antibiotics within 1hour, 4) Infuse a rapid fluid bolus of 30mL/kg isotonic crystalloid for hypotension or lactate ≥4.0mmol/L, and 5) Apply norepinephrine for refractory MAP<65mmHg.
Anaphylactic Shock ("Airway & Allergen")
A Type I IgE-mediated distributive shock triggered by massive histamine release leading to life-threatening bronchoconstriction and systemic vasodilation; manifested by stridor, hoarseness, wheezing, angioedema, urticaria, hypotension, and tachycardia.
Intramuscular Epinephrine (1:1,000)
The mandatory first-line drug for anaphylactic shock administered immediately into the mid-anterolateral thigh, with repeat dosing every 5–15minutes as clinically indicated.
Neurogenic Shock ("Loss of Tone")
A distributive shock resulting from cervical or high-thoracic spinal cord injuries (≥T6) that disrupt sympathetic outflow, leaving parasympathetic vagal tone unopposed.
Classic Triad of Neurogenic Shock
The hallmark hemodynamic presentation of neurogenic shock consisting of: 1) Bradycardia, 2) Severe hypotension, and 3) Warm, dry, flushed skin below the level of the lesion (with poikilothermia).
Obstructive Shock ("Mechanical Block")
A shock state caused by physical impedance to cardiac inflow or outflow, most commonly produced by cardiac tamponade, tension pneumothorax, or massive pulmonary embolism.
Beck's Triad
The diagnostic clinical triad of cardiac tamponade consisting of jugular venous distention (JVD), muffled heart sounds, and hypotension; treated with emergent pericardiocentesis.
Needle Decompression in Tension Pneumothorax
The definitive emergency physical decompression performed at the 2nd or 3rd intercostal space mid-clavicular line for a tension pneumothorax manifesting with absent breath sounds, tracheal deviation to the opposite side, and JVD.
Massive Pulmonary Embolism Emergency Intervention
The definitive emergency management for an obstructive shock caused by sudden massive PE presenting with pleuritic pain, severe hypoxemia, and acute RV strain; requires immediate systemic thrombolytics (Alteplase/tPA) or embolectomy.
SIRS Criteria Matrix
Clinical matrix defining Systemic Inflammatory Response Syndrome by meeting ≥2 criteria: temperature >38.0∘C(100.4∘F) or <36.0∘C(96.8∘F); heart rate >90bpm; respiratory rate >20breaths/min or PaCO2<32mmHg; and WBC count >12,000/μL, <4,000/μL, or >10% immature band forms.
Serum Lactate Threshold in Deterioration
A serum lactate concentration exceeding 2.0mmol/L, which serves as a major metabolic indicator reflecting an early cellular switch from aerobic to anaerobic metabolism.
Kidney Functions ("A W E T B E D")
A memory acronym outlining renal functions: A - Acid-base balance, W - Water balance, E - Electrolyte balance, T - Toxin removal, B - Blood pressure control, E - Erythropoietin production, and D - Vitamin D activation.
Prerenal Acute Kidney Injury (AKI)
Etiology of AKI caused by hypoperfusion occurring before the kidney (absolute hypovolemia, hemorrhage, shock states, heart failure, renal artery stenosis); treated by restoring circulating volume with isotonic IV fluids and discontinuing diuretics.
Intrarenal Acute Kidney Injury (AKI)
Etiology of AKI caused by direct parenchymal or tubular damage within the kidney, triggered by nephrotoxins (NSAIDs, aminoglycosides, IV contrast, vancomycin), rhabdomyolysis, or acute glomerulonephritis.
Postrenal Acute Kidney Injury (AKI)
Etiology of AKI caused by mechanical obstruction of urine outflow distal to the kidneys (BPH, renal calculi, pelvic tumors, neurogenic bladder, blocked catheter); managed by immediate mechanical relief (Foley insertion, line irrigation, lithotripsy, nephrostomy).
AKI Onset Phase
The first phase of acute kidney injury that begins with the initial physiological insult and ends when oliguria develops; clinical focus is immediate removal of the precipitating cause.
AKI Oliguric Phase
The second phase of AKI lasting 1–3weeks, characterized by a urine output of 100–400mL/24hr and carrying severe risks of hyperkalemia, fluid overload, pulmonary edema, and metabolic acidosis.
AKI Diuretic Phase
The third phase of AKI marked by a surge in daily urine output to 1–5L/day because nephrons filter fluid but cannot yet concentrate urine, creating high risks for dehydration, severe hypokalemia, and hyponatremia.
AKI Recovery Phase
The fourth and final phase of AKI where glomerular filtration rate improves and BUN and creatinine stabilize toward normal baseline; complete recovery may take up to 12months.
IV Calcium Gluconate (in Hyperkalemia)
An emergency cardiac agent that immediately stabilizes myocardial membranes to prevent fatal dysrhythmias during severe hyperkalemia; it does NOT lower serum potassium levels.
IV Regular Insulin + Dextrose (D50W)
An emergency pharmacologic combination for hyperkalemia that rapidly drives extracellular potassium ions into the intracellular compartment, with dextrose co-administered to prevent acute hypoglycemia.
Sodium Bicarbonate in AKI/Acidosis
An intravenous alkalizing agent administered during acute hyperkalemia with concomitant metabolic acidosis to temporarily shift potassium ions into intracellular fluid.
Recommended Fluid Calculation in Oliguric AKI
A fluid restriction calculation formulated for oliguric renal failure where daily fluid allotment equals the total volume of the previous 24-hour urine output plus 500–600mL (insensible loss).
Chronic Kidney Disease (CKD)
The progressive, irreversible deterioration of kidney function and nephron architecture, most frequently caused by chronic diabetes mellitus and hypertension.
CKD Stage 1
Kidney damage evidenced by protein in the urine or structural changes, paired with a normal or high glomerular filtration rate defined as an eGFR≥90mL/min.
CKD Stage 2
Kidney damage accompanied by mild loss of renal function, defined as an eGFR of 60–89mL/min.
CKD Stage 3a/b
Kidney disease characterized by moderate loss of renal filtering capacity, defined as an eGFR of 30–59mL/min.
CKD Stage 4
Severe reduction in renal function, defined as an eGFR of 15–29mL/min, requiring active clinical preparation for renal replacement therapy (RRT).
CKD Stage 5 (End-Stage Renal Disease)
Complete kidney failure, defined as an eGFR<15mL/min, where life cannot be sustained without chronic hemodialysis, peritoneal dialysis, or renal transplantation.
Uremic Encephalopathy Priority Finding
A central nervous system complication of advanced uremia characterized by new acute confusion, altered mental status, asterixis, or seizures, representing an NCLEX "SEE FIRST" clinical priority.
Renal Osteodystrophy
A chronic skeletal complication of CKD resulting from hyperphosphatemia, hypocalcemia, and failure of renal calcitriol activation, leading to secondary hyperparathyroidism and bone demineralization.
Acute Glomerulonephritis (AGN)
An immune-complex disease occurring after a Group A streptococcal infection that causes capillary inflammation, cola/tea-colored urine (gross hematuria), RBC casts, oliguria, hypertension, and periorbital edema that is worse in the morning.
Nephrotic Syndrome
A glomerular condition marked by massive basement membrane permeability leaks, resulting in massive proteinuria (>3.5g/day), profound hypoalbuminemia (<3.0g/dL), severe generalized edema (anasarca), hyperlipidemia, and dark, frothy urine.
Anasarca
Severe, generalized massive dependent edema involving the subcutaneous tissues, peritoneal cavity (ascites), and scrotum/labia, characteristically seen in nephrotic syndrome.
Protein Restriction in Azotemic AGN
A dietary intervention prescribing protein restriction to 0.6–0.75g/kg/day when azotemia (elevated BUN) is present to reduce nitrogenous waste burden and slow kidney failure progression.
Indications for Emergent Dialysis
Clinical conditions requiring urgent renal replacement therapy: severe uremia (nausea, vomiting, cognitive changes, pruritus), persistent hyperkalemia, pulmonary edema refractory to diuretics, severe hypertension, severe metabolic acidosis, or medication/drug toxicities.
Arteriovenous (AV) Fistula Assessment (Thrill and Bruit)
A mandatory per-shift nursing vascular access assessment requiring light palpation of a continuous vibration (thrill) and auscultation of a whooshing sound (bruit) to confirm patency.
AV Fistula Limb Precautions
Safety rules mandating that the healthcare team NEVER measure blood pressure, draw blood, start an IV, or place tight, constrictive clothing or jewelry on the extremity with an active vascular access.
Dialysis Disequilibrium Syndrome
A neurologic complication caused by rapid fluid and solute/BUN clearance from the bloodstream creating a transient osmotic gradient that drives water into brain cells, causing cerebral edema, headache, nausea, altered LOC, restlessness, twitching, and seizures.
Peritonitis in Peritoneal Dialysis
A major peritoneal dialysis complication where the earliest and classic clinical indicator is cloudy, turbid, or opaque dialysate effluent, frequently accompanied by fever and rebound abdominal pain.
Dialysate Warming Rule
A clinical skill requirement mandating that peritoneal dialysate solution be warmed with a heating pad or commercial warmer only, and NEVER warmed in a microwave oven to avoid uneven burns.
Poor Outflow Interventions in Peritoneal Dialysis
Stepwise troubleshooting actions for low drainage during PD: assess for tubing kinks, check clamps, rotate or reposition the client side-to-side, treat constipation, milk the tubing, and ensure the drainage bag hangs below the abdomen.
Living Related Donor Kidney Allograft
The optimal source for renal transplantation providing the highest long-term graft survival rates due to optimal HLA and ABO immunologic compatibility.
Pre-Transplant Hemodialysis Timing
The standard protocol requiring hemodialysis to be completed within 24hours prior to transplant surgery to correct hyperkalemia and optimize circulating volume.
Post-Renal Transplant Hourly Urine Output Target
A postoperative monitoring standard expecting urine output to be >30mL/hr, with an abrupt drop or output <30mL/hr requiring immediate provider notification.
Mannitol in Renal Transplantation
An osmotic diuretic administered postoperatively to draw filtered water into renal nephrons, preserve urine flow, and prevent acute kidney injury.
Continuous Bladder Irrigation (CBI) Post-Renal Transplant
A continuous irrigation system maintained postoperatively to prevent urinary catheter obstruction from blood clots, which could cause damaging retroperitoneal back-pressure on the new graft.
Hyperacute Renal Graft Rejection
An immediate humoral antibody-mediated rejection occurring within 48hours of surgery, presenting with high fever, marked hypertension, and localized graft pain; requires immediate surgical nephrectomy.
Acute Renal Graft Rejection
A cell-mediated rejection occurring from 1week to 2years post-transplant, manifested by oliguria/anuria, low-grade fever, hypertension, graft tenderness, fluid retention, and rising BUN/Cr; treated with pulse corticosteroids.
Chronic Renal Graft Rejection
An insidious immune rejection occurring over months to years manifested by a gradual increase in azotemia, fluid retention, electrolyte imbalances, and fatigue; managed conservatively until dialysis is resumed.
Grapefruit Juice Interaction with Calcineurin Inhibitors
A food-drug interaction where grapefruit or its juice strongly inhibits the intestinal CYP3A4 enzyme, leading to toxic, dangerously elevated blood levels of cyclosporine and tacrolimus.
Medication-Induced Neutropenia Precautions
An infection prevention bundle for post-transplant clients: strict hand hygiene, reporting temperature >100∘F(37.8∘C), avoiding raw meat/produce, removing live plants and standing water, avoiding live vaccines (MMR, Varicella, Rotavirus), and using only electric razors.
Angiotensin-Converting Enzyme Inhibitors (ACE-Is) in CKD
Renal medications (lisinopril, enalapril) that block conversion of angiotensin I to angiotensin II, decreasing proteinuria and slowing CKD progression; side effects include dry cough, angioedema, and elevated potassium levels.
Angiotensin Receptor Blockers (ARBs) Precautions
Antihypertensive agents (losartan, valsartan) blocking angiotensin II receptors; nursing precautions include monitoring for first-dose hypotension, angioedema risk, avoiding NSAIDs, and observing absolute contraindication in pregnancy (teratogenic).
Erythropoietin (Epogen / Procrit) Administration Rules
A synthetic glycoprotein stimulating bone marrow RBC production in CKD anemia; it is contraindicated in uncontrolled hypertension and must NOT be administered if hemoglobin exceeds 12g/dL.
Oral Iron Administration Guidelines
Clinical instructions directing administration on an empty stomach (1hour before meals), diluting liquid iron in water/juice and taking through a straw with subsequent oral rinsing, and warning clients that stools will turn black or dark green.
Sodium Polystyrene Sulfonate (Kayexalate)
A cation-exchange resin that exchanges sodium for potassium in the colon to excrete potassium in stool over 4–6hours (not for emergency hyperkalemia; maximum dose 40g); strictly contraindicated in paralytic ileus or bowel obstruction.
Aluminum Hydroxide (Phosphate Binder)
A short-term phosphate binder used when calcium-based binders fail; carries adverse effects of severe constipation, fluid retention, and hypophosphatemia, and must be spaced 1–2hours apart from other oral medications.
Calcium Carbonate (Phosphate Binder)
A medication prescribed to bind dietary phosphorus directly in the gastrointestinal tract, preventing hyperphosphatemia and secondary hyperparathyroidism in CKD; must be taken with meals.
Sodium Bicarbonate "2-Hour Rule"
A clinical rule specifying that oral sodium bicarbonate alkalizers must not be administered within 2hours of other oral medications to prevent interference with drug absorption.
Cirrhosis Definition & Key Causes
A chronic progressive liver disorder where healthy hepatic parenchyma is replaced with diffuse fibrous scar tissue; key etiologies include alcohol use disorder (Laennec), viral hepatitis B, C, or D (postnecrotic), and NAFLD/NASH.
Liver Functions ("PUSHDOG")
A mnemonic summarizing liver physiology: P - Protein synthesis, U - Urea production (ammonia to urea), S - Storage (vitamins A, D, E, K), H - Hormone synthesis, DO - Detoxification, and G - Glucose and fat metabolism.
Portal Hypertension
Increased resistance and pressure within the portal venous system leading to collateral vessel formation, splenomegaly (causing platelet sequestration/thrombocytopenia), ascites, and esophageal varices.
Esophageal Varices Precautions
Clinical precautions for fragile, tortuous submucosal esophageal veins prone to catastrophic hemorrhage; patients must avoid NSAIDs, alcohol, straining, and rough or coarse foods.
Hepatic Encephalopathy Pathophysiology
A neuropsychiatric syndrome resulting from the diseased liver's inability to convert toxic ammonia into urea, allowing ammonia to cross the blood-brain barrier and cause cognitive dysfunction, asterixis, and coma.
Asterixis
A coarse, flapping tremor of the hands upon extension and wrist dorsiflexion, representing a cardinal sign of worsening hepatic encephalopathy and uremia.
Fetor Hepaticus
A distinctive sweet, musty, or fruity breath odor observed in severe hepatic failure caused by circulating volatile metabolic byproducts.
Lactulose in Hepatic Encephalopathy
An osmotic laxative that acidifies the colon to draw ammonia from the blood into the stool, with therapy titrated to produce 2–3 soft bowel movements per day.
Neomycin in Hepatic Encephalopathy
An oral aminoglycoside antibiotic prescribed to suppress normal intestinal bacterial flora that generate ammonia, reducing systemic ammonia production.
Spider Angiomas and Palmar Erythema
Cutaneous vascular findings in cirrhosis caused by impaired hepatic metabolism and clearance of circulating estrogens, resulting in small dilated arteriole spider patterns and reddened palms.
Hepatitis A Transmission and Incubation
An acute, self-limited viral infection transmitted via the fecal-oral route through contaminated food/water or close contact; features an incubation period of 15–50days and does not progress to chronic disease.
Hepatitis B Transmission and Incubation
A viral infection transmitted via infected blood, semen, body fluids, needles, or perinatal contact; has an incubation period of 60–150days, can become chronic, and is vaccine-preventable.
Hepatitis C Transmission and Treatment
A bloodborne viral infection primarily spread via shared injection equipment; incubation lasts 14–182days, commonly causes chronic cirrhosis/carcinoma, lacks a vaccine, but can be cured with an 8–12week course of direct-acting antivirals.
AST and ALT Trends in Liver Pathology
Enzyme indicators of hepatocellular injury (AST normal 5–40unit/L; ALT normal 8–20unit/L) where rising values signify ongoing hepatocellular necrosis or allograft rejection, and downward trends toward baseline indicate recovery.
Serum Ammonia in Cirrhosis
A laboratory metric (normal 11–32μmol/L) reflecting hepatic metabolic capacity; elevations correspond with increasing confusion, asterixis, and decreased LOC in hepatic encephalopathy.
Acute Liver Allograft Rejection (Days 4–10)
Early acute graft rejection presenting with tachycardia, unexplained fever spike, right upper quadrant pain, worsening jaundice, sudden drop or color change in bile, and surging AST, ALT, bilirubin, and alkaline phosphatase.
T-Tube Drainage Bag Management
Post-liver transplant biliary tube care requiring the drainage bag to be maintained in a dependent position below the gallbladder/liver, tracking drainage color (bloody transitioning to golden-brown/green), and NEVER irrigating, aspirating, or clamping without a provider order.
Post-Liver Transplant Activity Restrictions
Long-term client activity teaching: avoid lifting heavy objects during recovery, gradually increase ambulation as tolerated, and strictly avoid contact sports to safeguard the new liver graft.
Respiratory Acidosis
An acid-base disturbance caused by alveolar hypoventilation and CO2 retention (COPD, opioid depression, pneumonia, pulmonary edema); assessment shows bradypnea, dyspnea, confusion, and warm/flushed skin.
Respiratory Alkalosis
An acid-base imbalance caused by hyperventilation and excessive CO2 exhalation (anxiety, severe pain, fever, early sepsis, excess mechanical ventilation); manifested by tachypnea, perioral tingling, numbness, and tetany.
Metabolic Acidosis & Kussmaul Respirations
An acid-base disturbance resulting from acid accumulation or bicarbonate loss (DKA, lactic acidosis, renal failure, diarrhea); characteristically manifested by deep, rapid Kussmaul respirations attempting respiratory compensation.
Metabolic Alkalosis
An acid-base disturbance caused by excessive acid loss (severe vomiting, nasogastric suction, loop diuretics) or excess base intake; manifested by hypoventilation, muscle cramping, twitching, and hypokalemia.
Acetaminophen Maximum Daily Dosage Limits
Strict clinical safety limits capping daily acetaminophen intake at 4g/day for healthy adults, 3g/day for undernourished individuals, and 2g/day for clients consuming more than three alcoholic drinks daily.
Acetylcysteine Administration Route
The specific nursing practice of administering oral/liquid acetylcysteine antidote for acetaminophen poisoning through a duodenal tube to bypass vomiting and reduce aspiration risk.
Proton Pump Inhibitors (PPIs) Long-Term Adverse Effects
Complications linked to prolonged omeprazole or pantoprazole therapy, including hypomagnesemia, vitamin B12 deficiency, osteoporotic fractures, and increased vulnerability to Clostridioides difficile colitis.
Blood Transfusion Verification and Timing Rules
Safety mandates requiring two licensed nurses to verify recipient identity, unit number, ABO/Rh type, and expiration date; blood must be initiated within 30minutes of leaving the blood bank and finished within 2–4hours, with the nurse remaining at the bedside for the first 15minutes.
Acute Hemolytic Transfusion Reaction
A severe immune-mediated lysis of donor red blood cells caused by ABO incompatibility; key cues include fever, chills, low back pain, chest pain, hypotension, and hemoglobinuria; requires immediate transfusion cessation and infusion of fresh normal saline using brand-new tubing.
Transfusion-Associated Circulatory Overload (TACO)
A cardiopulmonary complication occurring when blood products are infused too rapidly or excessively, marked by dyspnea, bilateral pulmonary crackles, jugular venous distention, hypertension, and cough.
Continuous Lateral Uterine Displacement (LUD)
A mandatory resuscitation maneuver during CPR on a pregnant client where the gravid uterus is manually shifted to the mother's left side (or tilted laterally) to relieve aortocaval and inferior vena cava compression.